These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20592720)

  • 21. The COPD Pipeline XIII.
    Gross NJ
    COPD; 2011 Dec; 8(6):464-5. PubMed ID: 22149408
    [No Abstract]   [Full Text] [Related]  

  • 22. To measure is to know: an approach to CADD performance metrics.
    Loughney D; Claus BL; Johnson SR
    Drug Discov Today; 2011 Jul; 16(13-14):548-54. PubMed ID: 21605697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Open-access public-private partnerships to enable drug discovery--new approaches.
    Müller S; Weigelt J
    IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug development in Japan from the viewpoints of global pharmaceutical companies].
    Seriu T
    Rinsho Ketsueki; 2009 Jul; 50(7):556-62. PubMed ID: 19638723
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical research and drug development of antivirals in HIV: an industry perspective.
    Carter SK
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S107-113. PubMed ID: 7552507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality by design in lead optimization: a new strategy to address productivity in drug discovery.
    Rossi T; Braggio S
    Curr Opin Pharmacol; 2011 Oct; 11(5):515-20. PubMed ID: 21652263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doctors, pharmacy students and drug companies: a first week of research in Pakistan.
    Jamshed S
    JNMA J Nepal Med Assoc; 2009; 48(174):198. PubMed ID: 20387370
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug research in Germany--problems and chances--from the viewpoint of the drug industry].
    Weihrauch TR; Baumbauer E
    Arzneimittelforschung; 1998 Nov; 48(11):1047-50. PubMed ID: 9850422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experiences with learning and confirming in drug and biological development.
    Patterson SD
    Clin Pharmacol Ther; 2010 Aug; 88(2):161-3. PubMed ID: 20648033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical research: outlook from industry.
    Echols R
    Clin Perform Qual Health Care; 1996; 4(2):113-4. PubMed ID: 10156942
    [No Abstract]   [Full Text] [Related]  

  • 32. Improving R&D productivity.
    Smietana K; Ekstrom L; Jeffery B; Møller M
    Nat Rev Drug Discov; 2015 Jul; 14(7):455-6. PubMed ID: 26065405
    [No Abstract]   [Full Text] [Related]  

  • 33. Brand-name drug companies fail to meet R&D commitments.
    Kondro W
    CMAJ; 2006 Aug; 175(4):344. PubMed ID: 16908891
    [No Abstract]   [Full Text] [Related]  

  • 34. Paediatric pharmacological principles: an update. Part 1: Drug development and pharmacodynamics.
    Kanneh A
    Paediatr Nurs; 2002 Oct; 14(8):36-42. PubMed ID: 12432618
    [No Abstract]   [Full Text] [Related]  

  • 35. Update of FDA's Critical Path Initiative.
    Khleif S
    Clin Adv Hematol Oncol; 2009 Mar; 7(3):173-4. PubMed ID: 19398939
    [No Abstract]   [Full Text] [Related]  

  • 36. Overcoming the obstacles in the pharma/biotech industry: 2009 update.
    Graul AI; Revel L; Tell M; Rosa E; Cruces E
    Drug News Perspect; 2010; 23(1):48-63. PubMed ID: 20155219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research and development productivity map: visualization of industry status.
    Shimura H; Masuda S; Kimura H
    J Clin Pharm Ther; 2014 Apr; 39(2):175-80. PubMed ID: 24438433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pipelines turn to biotech.
    Lawrence S
    Nat Biotechnol; 2007 Dec; 25(12):1342. PubMed ID: 18066015
    [No Abstract]   [Full Text] [Related]  

  • 39. Closing the gap.
    Nat Rev Drug Discov; 2006 Feb; 5(2):89. PubMed ID: 16521323
    [No Abstract]   [Full Text] [Related]  

  • 40. Promoting, improving and accelerating the drug development and approval processes.
    Graul AI
    Drug News Perspect; 2009; 22(1):30-8. PubMed ID: 19209297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.